2014
DOI: 10.1016/j.drudis.2014.06.014
|View full text |Cite
|
Sign up to set email alerts
|

Targeting the Wnt signaling pathways in pulmonary arterial hypertension

Abstract: Pulmonary arterial hypertension (PAH) is a life-threatening disorder that is associated with elevated pulmonary pressures and right heart failure resulting from progressive loss and thickening of small pulmonary arteries. Despite their ability to improve symptoms, current therapies fail to prevent disease progression, leaving lung transplantation as the only therapy in end-stage PAH. To overcome the limitations of current therapies, there is an active search for disease-modifying agents capable of altering the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
32
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 43 publications
(38 citation statements)
references
References 47 publications
(46 reference statements)
2
32
0
Order By: Relevance
“…PAH is a chronic progressive and fatal disease ( 24 ), which is characterized by a continuous increase in pulmonary vascular resistance and pulmonary arterial pressure, leading to right heart failure and death ( 25 ). The pathogenesis of PAH is associated with inflammation, increased vascular tension and hPASMC proliferation, as well as resistance to apoptosis ( 4 ).…”
Section: Discussionmentioning
confidence: 99%
“…PAH is a chronic progressive and fatal disease ( 24 ), which is characterized by a continuous increase in pulmonary vascular resistance and pulmonary arterial pressure, leading to right heart failure and death ( 25 ). The pathogenesis of PAH is associated with inflammation, increased vascular tension and hPASMC proliferation, as well as resistance to apoptosis ( 4 ).…”
Section: Discussionmentioning
confidence: 99%
“…In the first one, activation of Wnt leads to GSK-3β inhibition and Snail-and β-catenin-induced EndoMT [3,15,16]. In the noncanonical one, Wnt activates GTPases Rac/Rho/cdc42, all involved in migration and cytoskeleton rearrangement [24]. Several growth factor signaling that act through RTKs are found up-regulated in PAH, including epidermal growth factor, fibroblast growth factor, vascular endothelial growth factor and platelet-derived growth factor [1].…”
Section: Molecular Pathways Of Endomt In Pahmentioning
confidence: 99%
“… 18 , 19 In addition to pulmonary fibrosis, the Wnt/β-catenin signaling pathway has important roles in pulmonary arterial hypertension, in which vascular smooth muscle cell proliferation is a key characteristic. 20 …”
Section: Introductionmentioning
confidence: 99%